Genaissance: Personalized medicines

The process of drug discovery for protein targets generally is aimed at discovering compounds active against only one form of that protein, chosen arbitrarily from among the multiple isogenes (variants) that exist in the population. It follows that a drug designed to react with only one variant of a target protein may not be equally active against all the forms it encounters.

For Genaissance Pharmaceuticals, formed earlier this year

Read the full 680 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE